As we enter 2025 Q2, most 340B hospitals are struggling to protect their programs from further prescription-savings erosion. What’s particularly sad about this is that hospitals taking full advantage of ongoing advances in overcoming manufacturer restrictions and other 340B challenges are asking themselves how they can further OPTIMIZE their 340B savings. All of which is why the ultimate question for a 340B-eligible entity might be: Which group is your hospital in: The former, or the latter? To learn how we can help your health system, contact Howard Hall. howard.hall@proxsysrx.com | 214.808.2700 #Healthcare #Pharmacy #Mission #340B
